Innovative Respiratory Platform Cohero Health offers a proprietary connected health platform that combines inhaler sensors and mobile spirometers to improve adherence and lung function monitoring, presenting opportunities for partnerships with healthcare providers and respiratory medication companies aiming to enhance patient engagement and outcomes.

Strategic Industry Collaborations Recent partnerships with big pharma and tech companies, including AstraZeneca and ŌURA, demonstrate active expansion into neurology, migraine, and neurological disease markets, opening avenues to sell digital health solutions and integrated device platforms to pharmaceutical companies seeking patient-centered innovations.

Growing Digital Health Portfolio The acquisition of Healint and collaborations aimed at developing AI-powered screening algorithms indicate an expanding product ecosystem, providing potential sales opportunities in AI-driven diagnostics and chronic disease management solutions targeting healthcare systems and insurers.

Focus on Neurological Diseases Partnerships with Biogen and research collaborations with the University of Geneva highlight a targeted focus on neurological and rare diseases, creating potential avenues to offer specialized digital health tools for clinical trials, disease monitoring, and therapeutic support providers.

Emerging Market Position With a revenue range of 1 million to 10 million and recent high-profile collaborations, Cohero Health is positioned for growth in digital respiratory and neurological health markets, making it an attractive prospect for strategic partners and investors looking to enter or expand within the digital health space.